Диссертация (1139571), страница 30
Текст из файла (страница 30)
26, №. 4. – С. 514-516.105. Bagirova, N.S. Current state of bacteriemia diagnostics / N.S. Bagirova //Soprovoditefnaya terapiya v onkologii. – 2006. – Vol. 3. – Р. 23-38.106. Bagnoli, F. A second pilus type in Streptococcus pneumoniae is prevalent inemerging serotypes and mediates adhesion to host cells // F. Bagnoli, M.Moschioni, C.
Donati et al. // Journal of Bacteriology. – 2008. – Vol. 190. – Р.5480-5492.199107. Barantsevich, E.P. Emergence of Klebsiella pneumoniae producing NDM-1carbapenemase in Saint Petersburg, Russia / E.P. Barantsevich, I.V. Churkina,N.E. Barantsevich, J. Pelkonen, E.V. Schlyakhto, N.Woodford // Journal ofAntimicrobial Chemotherapy. – 2013. – Vol.
68, № 5. – Р. 1204-6.108. Barkai, G. Community prescribing and resistant Streptococcus pneumoniae // G.Barkai, D. Greenberg, N. Givon-Lavi, E. Dreifuss, D. Vardy, R. Dagan. //Emerging Infectious Diseases. – 2005. – Vol. 11. – Р. 829-837.109. Baron, E.J. Prolonged incubation and extensive subculturing do not increaserecovery of clinically significant microorganisms from standard automated bloodcultures / E.J. Baron, J.D. Scott, L.S.
Tompkins // Clinical Infectious Diseases. –2005. – Vol. 41. – Р. 1677-1680.110. Bassetti, M. Pseudomonas aeruginosa serious infections: mono or combinationantimicrobial therapy? / M. Bassetti, E. Righi, C. Viscoli // Current MedicinalChemistry. – 2008. – Vol. 14. – P. 517–522.111.
Beall, B. Pre- and postvaccination clonal compositions of invasive pneumococcalserotypes for isolates collected in the United States in 1999, 2001, and 2002 / B.Beall, M.C. McEllistrem, R.E. Gertz Jr, S.Wedel, D.J. Boxrud, A.L. Gonzalez, etal. // Journal of Clinical Microbiology. – 2006. – Vol. 44. – P. 999–1017.112. Beall, B. Shifting genetic structure of invasive serotype 19A pneumococci inthe United States / B.
Beall, R. Gertz, R. Hulkower, et al. // Clinical InfectiousDiseases. – 2011. – Vol. 203. – P. 1360-1368.113. Bemer-Melchior, P. In vitro activity of new ketolide telithromycin comparedwith those of macrolides against Streptococcus pyogenes: influences of resistancemechanisms and methodological factors / P. Bemer-Melchior, M.E. Juvin, S.Tassin, A. Bryskier, G.C. Schito, H-B. Drugeon // Antimicrobial Agents andChemotherapy. – 2000.
– Vol. 44, № 11. – Р. 2999-3002.114. Bender, J.M. Pneumococcal necrotizing pneumonia in Utah: does serotypematter? / J.M. Bende, K. Ampofo, K. Korgenski, J. Daly, A.T. Pavia, et al. //Clinical Infectious Diseases. – 2008. – Vol. 46, № 9. – Р. 1346-52.200115. Bernards, A.T. Persistent Acinetobacter baumannii? Look inside your medicalequipment / A.T. Bernards, H.I.
Harinck, L. Dijkshoorn, T.J. van der Reijden et al// Infection Control and Hospital Epidemiology. – 2004. – Vol. 25. – P. 1002–1004.116. Bialek-Davenet, S. Genomic definition of hypervirulent and multidrug-resistantKlebsiella pneumoniae clonal groups / S. Bialek-Davenet, A. Criscuolo, F.Ailloud, V.
Passet, et al. // Emerging Infectious Diseases. – 2014. – Vol. 20, №11. – Р. 1812-20.117. Bidet, P. Infections a Streptococcus pyogenes ou streptocoque du groupe Achez l’enfant: donnees du Centre national de reference (CNR) / P. Bidet, C.Plainvert, C. Doit, P. Mariani-Kurkdjian, et al. // Archives de pediatrie. – 2010. –Vol.
17. – Р. 201-208.118. Biedenbach, D.J. In vitro activity of oral antimicrobial agents against pathogensassociated with community-acquired upper respiratory tract and urinary tractinfections: a five country surveillance study / D.J. Biedenbach, R.E. Badal, M.Y.Huang, M. Motyl, et al. // Infectious Diseases and Therapy.
– 2016. – Vol. 5. – Р.139-53.119. Biesbroek,G.Seven-valentpneumococcalconjugatevaccineandnasopharyngeal microbiota in healthy children / G. Biesbroek, X. Wang, B.J.Keijser et al. // Emerging Infectious Diseases. – 2014. – Vol. 20. – Р. 201-10.120. Biesbroek, G. The impact of breastfeeding on nasopharyngeal microbialcommunities in infants / G. Biesbroek, A.A. Bosch, X. Wang, B.J. Keijser, et al.American Journal of Respiratory and Critical Care Medicine. – 2014.
– Vol.190,№ 3. – Р. 298-308.121. Boucher, H.W. Bad bugs, no drugs: no ESKAPE! An update from the InfectiousDiseases Society of America / H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E.Edwards et al // Clinical Infectious Diseases. – 2009. – Vol . 48, №1/ - P. 1-12.122. Bovo, R. Pseudomonas and Aspergillus interaction in malignant external otitis:risk of treatment failure / R. Bovo, A. Benatti, A.Ciorba, Libanore, M. Borrelli etal // Otorhinolaryngologica Italica. – 2012.
– Т. 32, №. 6. – С. 416 – 9.201123. Bush, K. Proliferation and significance of clinically relevant beta-lactamases /K. Bush // Annals of the New York Academy of Sciences. – 2013. – Vol.1277. –P. 84-90.124. Butler, J.C. Serotype Distribution of Streptococcus pneumoniae infectionsamong Preschool children in the United States, 1978-1994: Implications forDevelopment of a Conjugate Vaccine / J.C. Butler, R.F. Breiman, H.B. Lipman,Jo. Hofman, R.R.
Facklam // The Journal of Infectious Diseases. – 1995. – Vol.171. – Р. 885-889.125. Calhoun, J. H. Multidrug-resistant organisms in military wounds from Iraq andAfghanistan / J. H. Calhoun, C. K. Murray, M. M. Manring// Clinicalorthopaedics and related research. – 2008. – Vol. 466, №. 6. – P. 1356-1362.126. Campodоnico, V. L. Airway epithelial control of Pseudomonas aeruginosainfection in cystic fibrosis / V.
L. Campodоnico, M. Gadjeva, C. Paradis-Bleau,A. Uluer, G. B. Pier // Trends in molecular medicine. – 2008. – Vol. 14, №. 3. –P. 120-133127. Carek, P. J. Diagnosis and management of osteomyelitis / P. J. Carek, L. M.Dickerson, J. L. Sack // American family physician. – 2001. – Vol. 63, № 12. – P.2413-2420.128. Carretto, E. Widespread carbapenem resistant Acinetobacter baumannii clonesin Italian hospitals revealed by a multicenter study / E. Carretto, D.
Barbarini, L.Dijkshoorn, T.J. van der Reijden, S. Brisse, V. Passet, C. Farina. // Infection,Genetics and Evolution. – 2011. – Vol. 11. – Р.1319-26.129. Cerqueira, G.M. Insights into Acinetobacter baumannii pathogenicity / G.M.Cerqueira, A.Y. Peleg // Journal of the International Union of Biochemistry andMolecular Biology. – 2011. – Vol.
63, № 12. – P. 1055–1060.130. Chastre, J. Ventilator-associated pneumonia / J. Chastre, J. Y. Fagon //Americanjournal of respiratory and critical care medicine. – 2002. – Vol. 165, №. 7. – P.867-903.131. Chebotkevich, V.N. Modern laboratory diagnostic techniques of sepsis / V.N.Chebotkevich,E.I.Kaytandzhan,V.V.Burylev,E.E.Shchetinkina//202Klinicheskaya mikrobiologiya i antimikrobnaya khimioteriya. – 2013. – Vol.15,№ 4. – Р. 295-300.132. Chen, H.H. Fluoroquinolone-nonsusceptible Streptococcus pneumoniae isolatesfrom a medical center in the pneumococcal conjugate vaccine era / H.H. Chen,H.C. Li, L.H. Su, C.H.
Chiu // Journal Of Microbiology Immunology AndInfection. – 2017. – Vol.50, №6. – Р. 839-845.133. Choi, E.H. Streptococcus pneumoniae serotype 19A in children, South Korea /E.H. Choi, S.H. Kim, B.W. Eun et al. // Emerging Infectious Diseases. – 2008. –Vol.14. – Р. 275-81.134. Chotirmall, S. H. Candida species in cystic fibrosis: a road less travelled / S. H.Chotirmall, C.
M. Greene, N. G. McElvaney // Medical Mycology. – 2010. – Vol.48, № 1. – P.114-124.135. Chuang, C. H. Shanghai fever: a distinct Pseudomonas aeruginosa entericdisease / C. H. Chuang, , Y. H. Wang, H. J. Chang, H. L.Chen, et al // Journal Gut.– 2014. – Vol. 63, № 5. – P. 736-743.136.
Clinical and Laboratory Standards Institute. Performance Standards forAntimicrobial Susceptibility Testing: Twenty-sixth Edition. CLSI SupplementM100S. CLSI, Wayne, PA, USA, 2016.137. Cohen, R. Impact of 13-valent pneumococcal conjugate vaccine onpneumococcal nasopharyngeal carriage in children with acute otitis media / R.Cohen, C. Levy, E. Bingen, M. Koskas, I. Nave, E. Varon // The PediatricInfectious Disease Journal.
– 2012. – Vol.31. – Р. 297-301.138. Cohen, R. Le streptocoque du groupe A. Un pathogene majeur pour la prochainedecennie? Streptococcus pyogenes an emerging pathogen / R. Cohen, Y. Aujard,P. Bidet, A. Bourrillon, et al. // Archives de pediatrie. – 2005. – Vol.12. – Р.1065-1067.139. Comite de L'Antibiogramme de la Societe Francaise de Microbiologie.Recommandations 2012.
Concentrations, diametres critiques et regles de lectureinterpretative (Tableau XIX). www.sfm-microbiologie.org203140. Cornick, J.E. Streptococcus pneumoniae: the evolution of antimicrobialresistance to beta-lactams, fluoroquinolones and macrolides / J.E. Cornick, S.D.Bentley // Emerging Microbes and Infections. – 2012. – Vol. 14. – P.573-83.141. Cox, C.
D. Use of 2-aminoacetophenone production in identification ofPseudomonas aeruginosa / C. D. Cox, J. Parker // Journal of clinical microbiology.– 1979. – Vol. 9, №. 4. – P. 479-484.142. Croucher, N.J. Rapid pneumococcal evolution in response to clinicalinterventions / N.J. Croucher, S.R. Harris, C. Fraser, M.A. Quail, et al. // Science.– 2011. – Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
